Lantheus Holdings, Inc. (LNTH) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | Payments of Dividends |
| Net income · 12 months | 275.31M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $275.31M | (m) |
| 2026-03-31 | (m) | $279.03M | (m) |
| 2025-12-31 | (m) | $233.56M | (m) |
| 2025-09-30 | (m) | $167.68M | (m) |
| 2025-06-30 | (m) | $271.00M | (m) |
| 2025-03-31 | (m) | $254.32M | (m) |
| 2024-12-31 | (m) | $312.44M | (m) |
| 2024-09-30 | (m) | $427.61M | (m) |
| 2024-06-30 | (m) | $428.48M | (m) |
| 2024-03-31 | (m) | $460.53M | (m) |
| 2023-12-31 | (m) | $326.66M | (m) |
| 2023-09-30 | (m) | $104.10M | (m) |
| 2023-06-30 | (m) | $33.37M | (m) |
| 2023-03-31 | (m) | $-17.70M | (m) |
| 2022-12-31 | (m) | $28.07M | (m) |
| 2022-09-30 | (m) | $107.04M | (m) |
| 2022-06-30 | (m) | $32.39M | (m) |
| 2022-03-31 | (m) | $-37.33M | (m) |
| 2021-12-31 | (m) | $-71.28M | (m) |
| 2021-09-30 | (m) | $-34.48M | (m) |
| 2021-06-30 | (m) | $-27.45M | (m) |
| 2021-03-31 | (m) | $-7.80M | (m) |
| 2020-12-31 | (m) | $-13.47M | (m) |
| 2020-09-30 | (m) | $389.00K | (m) |
| 2020-06-30 | (m) | $11.63M | (m) |
| 2020-03-31 | (m) | $25.05M | (m) |
| 2019-12-31 | (m) | $31.67M | (m) |
| 2019-09-30 | (m) | $34.51M | (m) |
| 2019-06-30 | (m) | $38.92M | (m) |
| 2019-03-31 | (m) | $42.26M | (m) |
| 2018-12-31 | (m) | $40.52M | (m) |
| 2018-09-30 | (m) | $124.35M | (m) |
| 2018-06-30 | (m) | $123.61M | (m) |
| 2018-03-31 | (m) | $127.46M | (m) |
| 2017-12-31 | (m) | $123.39M | (m) |
| 2017-09-30 | (m) | $31.13M | (m) |
| 2017-06-30 | (m) | $26.82M | (m) |
| 2017-03-31 | (m) | $20.58M | (m) |
| 2016-12-31 | (m) | $26.76M | (m) |
| 2016-09-30 | (m) | $25.81M | (m) |
| 2016-06-30 | (m) | $26.98M | (m) |
| 2016-03-31 | (m) | $-4.80M | (m) |
| 2015-12-31 | (m) | $-14.75M | (m) |
| 2015-09-30 | (m) | $-18.43M | (m) |
| 2015-06-30 | (m) | $-24.69M | (m) |
| 2015-03-31 | (m) | $-1.90M | (m) |
| 2014-12-31 | (m) | $-3.56M | (m) |
| 2014-09-30 | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) |
| 2013-12-31 | $123.00K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |